New Research Shows Effectiveness of Light Disinfection Against COVID-19

Technology also proven to work against Influenza A

By HFT Editorial Staff


Newly published research shows that light disinfection technology effectively and safely inactivates SARS-CoV-2 and influenza A viruses in a range of real-world clinical settings.

The paper, "The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus," was published in Scientific Reports on September 30, 2021. It reflects how researchers evaluated the inactivation rate of the SARS-CoV-2 virus using 405 nm visible light under a range of clinical conditions. By applying these findings to a real-world usage model, it is determined that the technology would achieve a SARS-CoV-2 inactivation rate of 94 percent based on 12 hours of occupied room use and 12 hours of unoccupied room use.

The potential of specific wavelengths within the electromagnetic spectrum is an area of growing clinical interest. Ultraviolet (UV) technologies have demonstrated the ability to reduce virological spread, but potential toxicities have limited its use in occupied spaces. Longer wavelengths with less irradiation energy such as visible light (405 nanometers) have largely been evaluated in bactericidal and fungicidal applications. This research offers some of the strongest evidence to date of the real-world application of 405 nm visible light to inactivate the SARS-CoV-2 and influenza A viruses, helping to create safe, occupied spaces.

"Reducing the ability of SARS-CoV-2 and influenza A to spread within healthcare settings is paramount," says Adolfo Garcia-Sastre, Ph.D., Director of the Global Health & Emerging Pathogens Institute and Professor of Microbiology and Medicine at the Icahn School of Medicine at Mount Sinai and the study's lead investigator. "This research adds important findings to the medical literature. It shows the potential of a simple, non-invasive technological solution to achieve inactivation of these highly disruptive viruses and warrants further evaluation across a range of additional clinical settings to further validate its effectiveness and safety."

The research was published from a partnership between Kenall and the Icahn School of Medicine at Mount Sinai.



October 6, 2021


Topic Area: Infection Control


Recent Posts

Environmental Services and the Fight Against AMR Bacteria

Disinfecting and training are low-cost options that address the rising threat of antimicrobial-resistant bacteria.


97 Senior Care Facilities in Southeast Texas Lose Power After Hurricane

The power outages have created concerns for seniors’ health during the summer heat.


SouthCoast Health Struck by Data Security Event

The event occurred in June 2023, with the organization’s review just recently being completed.


Senior Care Facilities Construction Drops, Occupancy Increases

This is the twelfth consecutive quarter that occupancy has increased in the senior care market.


Carilion Clinic Receives $25 Million Donation for New Cancer Center

The new facility, dubbed the Carilion Taubman Cancer Center after its donors, is currently in the planning stages.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.